The goal of a successful pre-surgical evaluation is to capture multiple habitual seizures and, if indicated, also to obtain functional studies (SPECT, PET scans) that best define the epileptogenic zone. However, the optimal duration of monitoring necessary to achieve this goal in children is unclear. It is suggested that for the purposes of diagnosis and classification, monitoring longer than 3 days should be considered among adolescents with paroxysmal events occurring on less than a daily basis. 3 Only small number of articles address the occurrence of seizures in the LTM unit among patients undergoing pre-surgical workup. [4] [5] [6] [7] Pre-surgical monitoring can be expensive and may place the patient at risk for prolonged seizures and seizure clusters. To use this expensive resource (LTM) efficiently, our goal was to assess factors influencing seizure occurrence during a pre-surgical workup. The aim of this study was to examine the factors predicting the occurrence of single/multiple seizures in children undergoing pre-surgical monitoring in the LTM unit.
Methods

IRB approval
This study was approved by the Institutional Review Board at Boston Children's Hospital.
Inclusion criteria
We retrospectively reviewed the medical records of all consecutive pre-surgical admissions to the LTM Unit from October 2009 to May 2011. Only admissions in patients undergoing a noninvasive pre-surgical evaluation were included. Patients admitted for the characterization and classification of events were excluded. Only seizure events with an EEG correlate were included. Patients with early discharge ( 3 days) were excluded, as these patients were monitored for an insufficient length of time to capture seizures. Fig. 1 depicts the selection process of the patients whose data was used for the final analysis in this study.
Clinical information
Information on the occurrence of single and multiple (!3) seizures, as well as on the total number of seizures captured upon each admission, was abstracted from the medical records. A seizure was defined as an event with an EEG correlate.
Information, including demographic data on patients, neurological examination, seizure localization/type, presence of lesions on MRI, and number of antiepileptic medications (AED) used, were collected. Lesions included malformations of the cortical development, focal encephalomalacia or gliosis, mesial temporal lobe sclerosis, tumors, and vascular malformations (including Sturge Weber syndrome). Seizure localization included temporal and extra-temporal, multi-regional/non-localized, and generalized seizure onsets.
Seizure frequency assessment at baseline
The baseline seizure frequency over a period of at-least 3 months as reported by the patient or caregiver at the time of admission or last clinic visit was obtained. Because the baseline seizure frequency varied among patients, it was further categorized into 3 groups as follows: Low-frequency: 1 seizure/month; medium-frequency: >1 seizure/month to 1 seizure/week; and high-frequency: >1 seizure/week over a period of at least 3 95 96 101
995
Excluded admis sions on patients undergoing invasive pre -su rgica l evaluation or those admitted for the char acterization and classificati on of events 894
Excluded admis sions w ith early dis charge 01
Excluded admis sions w ith events with out EEG correlates
Retrospe ctive med ica l record review of all cons ecut ive e pilepsy ad mission s from Octobe r
-May 2011 995
Patients eli gib le for stu dy and da ta analysis : 95 admiss ions on 92 patien ts (3 patients wer e mon ito red t wice) Fig. 1 . Flow diagram showing the selection process for patients whose data were reviewed for analysis in the study. months. 8 If the caregiver reported minimal and maximal seizures per month, then the 2 numbers were averaged to calculate the seizure frequency. The time from admission to seizure onset was calculated in days, with noon of the day of admission to noon of the next day being counted as day 1.
The occurrence of prolonged seizures (>5-30 min) and status epilepticus (>30 min), 9 as well as the total length of stay, were collected. One hundred one admissions of 98 patients undergoing presurgical monitoring were initially identified. Five patients did not have an EEG correlate to their events, and one had an early discharge due to discordant data; these patients were subsequently excluded from the analysis. The final analysis included 95 admissions in 92 patients and included three children who were admitted twice; these admissions were counted as independent observations. A second analysis (not reported here) after excluding one observation each from these three patients was not significantly different from the reported analysis.
Anti-epileptic medication (AED) reduction
AED reduction is standard for patients undergoing LTM for presurgical/other monitoring. 5, 10, 11 As a standard protocol in our LTM unit, patients had a $50% reduction in dosage of their AEDs on day 1 after the PET scan, and AEDs were stopped completely on day 2.
Video-EEG
All patients admitted underwent continuous digital video-EEG monitoring throughout their hospitalization. Twenty-eight electrodes were placed according to the 10-20 international system to include FT9 and FT10 electrodes. Appropriate re-application, including the replacement ($10%) of electrodes based on a daily impedance check, was performed. The 24 h recording was screened by a trained technologist, and relevant samples were reviewed by a board-certified epileptologist.
Statistical analysis
The probability of having single/multiple seizures compared to reported seizure frequency, age, gender, duration of epilepsy, MRI lesions, seizure localization/type and number of AEDs used were performed using chi-square/fisher exact tests and simple (one predictor) logistic regression models; odds ratios with 95% confidence intervals, as well as Wald test p-values, were reported. Kaplan-Meier survival analysis was performed; survival curves were generated; and log-rank and likelihood-ratio test p-values were reported to determine the relationship between the time to first seizure and the baseline seizure frequency. All statistical analyses and graphics were created by SAS version 9.3 (SAS Inc., Cary, NC, USA) and Stata version 12 (Stata Inc., College Station, TX, USA).
Results
Demographics
We included data on 95 admissions of 92 patients (40 female) in the final analysis. Eighty-eight admissions had at least one seizure, while seventy-four had !3 seizures recorded during the monitoring. Seventeen admissions exhibited temporal seizure localization; 19, extra-temporal localization; 33, multi-regional/non-localized seizures; and 19, a generalized onset of their seizures. Sixty-four admissions underwent abnormal neurological examinations, and fifty-five admissions had lesions upon a brain MRI. The mean duration of epilepsy was 78 months.
Demographics and patient details are depicted in Table 1 .
Demographic characteristics, such as patient age, gender, MRI lesions, abnormal neurological exams, seizure localization/type, number of AEDs used (as a continuous variable), and duration of epilepsy were not significant predictors for the occurrence of any or multiple (3 or more) seizures (p > 0.1), either in all patients or separately in each home seizure frequency subgroup. Home seizure frequency was the only factor predicting the occurrence of any or multiple seizures (Fisher-exact test p = 0.01 and 0.0007, respectively).
Seizure frequency sub-group analysis
There were twenty-two admissions in the low-frequency, eighteen in the medium-frequency and fifty-five in the highfrequency group. Seventeen admissions in the low-frequency, seventeen in the medium-frequency, and fifty-four patients in the high-frequency group had at least one epileptic seizure during the monitoring period. All admissions in the medium and highfrequency group had a second seizure, while only 13 out of 22 admissions in the low-frequency group had a second seizure. Eleven out of twenty-two admissions in the low-frequency group had three or more seizures during the monitoring period compared to 14 (out of 18) in the medium-frequency group and 49 (out of 55) in the high-frequency group.
The odds of having a seizure increased by 15.88 (OR = 15.88, p = 0.01) in the high-frequency compared to low-frequency group. However, the odds of having a seizure did not significantly differ between the high-frequency and medium-frequency groups (OR = 3.17, p = 0.42) or between the medium-frequency and lowfrequency groups (OR = 5.0, p = 0.16).
The odds of having a second seizure increased in the highfrequency (OR = 37, p = 0.001) and medium-frequency groups (OR = 12, p = 0.03), compared to the low-frequency group. The odds of having a second seizure did not significantly differ between the medium-and high-frequency groups (OR = 3.18, p = 0.42).
The odds of having 3 or more seizures increased in the high (OR = 8.2, p = 0.0005) and medium-frequency groups (OR = 3.5, p = 0.007), compared to the low-frequency group. The odds of having 3 or more seizures did not significantly differ between the high and medium-frequency groups (OR = 0 2.3, p = 0.23).
The mean time to the first seizure onset among all admissions was 2.2 days (median 2), representing 2.7 days in the lowfrequency group (median 3), 2.1 days in the medium-frequency group (median 2), and two days in the high-frequency group (median 1.5).
The median time to second seizure was less than twenty-four hours from the first seizure in all three groups. In thirteen admissions, the time interval between the first and second seizure was longer than twenty-four hours (Table 2 ).
Seizure frequency and time to first seizure
Kaplan-Meier survival analysis showed that the time to onset of the first seizure in the high-frequency group was significantly less than that in the low-frequency group (log-rank and likelihoodratio, p = 0.0004 and 0.0014, respectively). Similarly, the time to onset of the first seizure in the medium-frequency group was significantly less than that in the low-frequency group (log-rank and likelihood-ratio, p = 0.038 and 0.038, respectively). The highand medium-frequency groups did not significantly differ in the time to onset for the first seizure (both log-rank and likelihoodratio, p > 0.1).
Kaplan-Meier survival analysis did not show any significant differences in the time to the occurrence of the second seizure from the first seizure in any 3 baseline seizure frequency categories (p > 0.1). Fig. 2 displays a composite of the Kaplan-Meier curves showing the survival probability of the 3 groups as a function of time to first seizure onset.
Seven out of the 95 admissions did not have a seizure during the monitoring period.
The mean length of stay for all admissions was 5 days in the high-frequency group, 6 days in the medium-frequency group and 5.5 days in the low-frequency group. Both the mean and median Fig. 2 . Kaplan-Meier survival curves demonstrating the relationship between time to first seizure and baseline seizure frequency. durations of stay in all admissions that had seizures during the monitoring period was five days. The mean length of stay in admissions for patients not experiencing a seizure was seven days (median 6). The total number of seizures captured during the monitoring period ranged from 0-18 seizures (median 2.5 seizures) in the lowfrequency group, 0-22 seizures (median 5.5) in the mediumfrequency group, and the highly variable range of 0-384 seizures in the high-frequency group (median 10) (Fig. 3) .
In our series, two admissions had status-epilepticus, and twelve admissions had prolonged seizures lasting between 5 and 30 min. None of the patients with prolonged seizures or status epilepticus required ICU care. Seven patients were in the high-frequency group, three were in the medium-frequency group, and two were in the low-frequency group. The two patients (in the lowfrequency group) received low-dose lorazepam (0.05 mg/kg) to stop their prolonged seizures but continued to have seizures the next day. Five patients received no treatment, and their prolonged seizures resolved spontaneously. The rest of the patients (n = 7) received benzodiazepine (n = 5), valproate (n = 1) and/or phenytoin (n = 3). Patients with status-epilepticus had electroclinical complex-partial seizures without overt tonic-clonic activity or any cardiopulmonary compromise.
Discussion
Summary
The majority of the LTM admissions for pre-surgical workup (92%) had at least one epileptic seizure during a stay of mean length 5.24 days. Home seizure frequency was the only factor influencing the occurrence of single or multiple seizures during monitoring. None of the other factors examined, such as age, gender, presence or absence of MRI lesions, seizure types and localization, number of AEDs used, abnormal neurological exam or duration of epilepsy modified the occurrence of single/multiple seizures in any of the patients or the individual sub-groups. Admissions with high or medium home seizure frequencies (>1/ month) were more likely to have multiple (3 or more) seizures in the LTM than those in the low-frequency group for a similar mean length of stay ($5 days). The time to the first epileptic seizure was shorter in the high-and medium-frequency groups (mean 2.1 days) than in the low-frequency group (mean 2.8 days).
Group differences
Home seizure frequency best predicted the occurrence of seizures. Although most of our admissions had at least 1 seizure during monitoring, the sub-group analysis on seizure frequency categories revealed that the low-seizure frequency group is at risk for completing the monitoring with a low number of seizures captured (<3).
We found that 98% of the high-frequency group versus 77% of the low-frequency group had a seizure during the monitoring. Todorov et al. 4 found that a 5-day stay was required to record at least 1 seizure in 90% of the patients evaluated for non-invasive and invasive pre-surgical monitoring. The authors did not relate their findings to home seizure frequency and assumed that the seizure frequency must be relatively high due to the selection of patients with refractory epilepsy. The occurrence of at least 1 seizure in most patients is most likely a reflection of the severity of disease observed in patients referred for a pre-surgical workup. This finding could also reflect the referral practices of the neurologists, who are biased towards referring children with very frequent seizures, as shown by the more than twice as large a number of patients being monitored in the high-frequency group than in the medium-and low-frequency groups in our series. Home seizure frequency also predicted the occurrence of multiple (!3) seizures during monitoring. The pre-surgical workup is considered successful if a consensus can be reached regarding the decision of whether to proceed with surgery. The ictal data obtained during multiple seizures provides information critical to successfully planning epilepsy surgery in a majority of cases. The optimal number of seizures needed to complete the pre-surgical workup varies depending upon several factors, including the quality of the video-EEG recording, the number of seizure types, and concordant data from other tests. It has been estimated that in cases of temporo-limbic epilepsy, a minimum of five seizures should be captured for the identification of the primary epileptogenic focus in adults. 12 Others have suggested that 3 or 4 identical events from a single seizure type may be sufficient to plan for epilepsy surgery in adults. 2 Nevertheless, clinically useful information may be gained even after 1 or 2 seizures. Among patients undergoing pre-surgical monitoring, various studies have reported that decisions regarding epilepsy surgery could be made in 55-69% of the cases. [5] [6] [7] The duration of monitoring in these studies ranged between 3.5-5 days. Although we did not examine whether the information obtained during LTM was sufficient to come to conclusions regarding epilepsy surgery in the groups studied, it is likely that the number of seizures captured during monitoring will impact the decision made regarding surgery. In our study, nearly half of all children in the low-frequency group did not have multiple seizures. Thus, we believe that the low-frequency group is possibly at risk for not successfully completing the presurgical monitoring. Previous adult studies have reported that the self-reporting of seizures is unreliable; unrecognized seizures are frequent, 13 and adult patients failed to document 55% of all recorded seizures in the LTM unit. 14 In contrast, few pediatric studies have suggested that the frequency of the paroxysmal events was the only factor determining the successful recording of that event during video-EEG monitoring, 5, 6 which is in agreement with our findings.
Underreporting may be less of a problem in the pediatric population compared to the adult population, as the parent/ caregiver tends to be more observant and can provide more reliable information about this vulnerable population. However, if the seizures are subtle, underreporting can still occur.
Time to first seizure
Our results in children regarding time-to-first-seizure onset were remarkably similar to those reported in the adult population. 10 Although we found that the difference in time-to-seizure occurrence was statistically significant between the low-frequency group and the other groups, we consider this difference (of less than one day) not to be clinically significant. A second seizure occurred within 24 h of the first seizure in all 3 groups, and this was not statistically significant among the groups. Hence, although the home seizure frequency influenced the occurrence of single/ multiple seizures during the period of monitoring, it did not appear to affect the time of occurrence of the seizures (either the first or the second seizure) in a clinically meaningful way.
Length of stay
The duration of monitoring can influence the number of seizures captured during LTM. The length of stay in our study was fairly consistent with that recorded in previous studies. 4, 5, 15 Another study 16 reported that 3 or more days were required to characterize paroxysmal episodes in 35% of their patients, as well as that it was not rare to require more than a week to observe the first event. Although it is possible that more patients in the lowfrequency group would have had a seizure if they stayed longer, children do not tolerate a longer duration of monitoring well; this often plays a major role in deciding the duration of monitoring. All of the patients in our series had a similar length of stay in the attempt to capture multiple seizures, regardless of their home seizure frequency. Our data could help to modify clinical practice if confirmed prospectively. To capture multiple seizures, a longer duration of monitoring, i.e., longer than 5-6 days (current practice), may be necessary for patients with a home seizure frequency of 1 seizure per month.
Five patients in the low-frequency group, and one in each of the medium-and high-frequency groups, did not have any seizures. The patient without a seizure in the high-frequency group turned out to have a nonepileptic event upon subsequent monitoring. If we exclude this patient from analysis, then all of patients in the high-frequency group had a seizure during the monitoring period.
Limitations
The main limitation of our study is the relatively small sample size in the low-/medium-frequency groups. This small sample size poses a risk for false-negative or false positive-results. Another limitation is the retrospective nature of the study. However, we included all consecutive patients admitted for a pre-surgical workup such that there was no inclusion bias. We believe that the study population provides a representative sample of patient admissions for such a work-up. The accuracy of parent-reported seizure-frequencies is a concern. We arbitrarily categorized the seizure frequency into 3 groups. Parents are better at reporting monthly, weekly or more than weekly seizures, and hence we chose this categorization. Although we find that certain highly motivated parents keep accurate seizure logs, most either do not maintain a seizure log or fail to produce it during a clinic visit. The data on management decisions based on pre-surgical video-EEG monitoring and post-surgical outcomes were not collected in our study. Because this is a retrospective observational analysis, the findings from this study must be verified prospectively.
Conclusions
Multiple seizures are required to demonstrate the consistency of ictal onset for the localization of epilepsy during pre-surgical monitoring. Home seizure frequency correlated with the occurrence of single/multiple seizures during LTM. None of the other factors (age/sex/MRI-lesions/neurological-exam/epilepsy-duration/seizure type and localization/AED usage) influenced the occurrence of single/multiple seizures during monitoring. Nearly half of all admissions in the low-frequency group (or 36% of those who had a seizure) did not have multiple (3 or more) seizures captured. This result may necessitate repeated monitoring or a lengthy inpatient stay during pre-surgical monitoring for low seizure frequency patients. Multiple ways of inducing seizures during LTM may also be helpful for at-risk patients (low seizure frequency group); these methods may include hyperventilation, 17, 18 sleep deprivation, a slow medication taper a few days before admission, photic stimulation or other triggers, such as circadian misalignment. In addition, cost has to be factored into the analysis when monitoring patients for pre-surgical evaluation because patients with low seizure frequencies may need a longer duration or repeat monitoring.
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